Search hospitals > Minnesota > Minneapolis
Minneapolis VA Health Care System, Minneapolis, MN
Claim this profileMinneapolis, Minnesota 55417
Global Leader in Lung Cancer
Global Leader in Post-Traumatic Stress Disorder
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Leukemia
391 reported clinical trials
31 medical researchers
Summary
Minneapolis VA Health Care System, Minneapolis, MN is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Non-Small Cell Lung Cancer, Cancer, Leukemia and other specialties. Minneapolis VA Health Care System, Minneapolis, MN is involved with conducting 391 clinical trials across 349 conditions. There are 31 research doctors associated with this hospital, such as Mark A. Klein, Sharon D. Luikart, Santiago Garcia, MD, and Kelvin Lim, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage I
2Post-Traumatic Stress Disorder
Global LeaderTop PIs
Mark A. KleinMinneapolis VA Medical Center5 years of reported clinical research
Studies Cancer
Studies Lung Cancer
14 reported clinical trials
24 drugs studied
Sharon D. LuikartMinneapolis VA Medical Center5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
13 reported clinical trials
24 drugs studied
Santiago Garcia, MDAbbott Northwestern Hospital6 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
13 reported clinical trials
17 drugs studied
Kelvin Lim, MDUniversity of Minnesota5 years of reported clinical research
Studies Transcranial Direct Current Stimulation
Studies Schizoaffective Disorder
5 reported clinical trials
5 drugs studied
Clinical Trials running at Minneapolis VA Health Care System, Minneapolis, MN
Lung Cancer
Non-Small Cell Lung Cancer
Post-Traumatic Stress Disorder
Prostate Cancer
Kidney Disease
Cancer
Amputation
Spinal Cord Injury
Heart Failure
Chronic Obstructive Pulmonary Disease
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Minneapolis VA Health Care System, Minneapolis, MN?
Minneapolis VA Health Care System, Minneapolis, MN is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Non-Small Cell Lung Cancer, Cancer, Leukemia and other specialties. Minneapolis VA Health Care System, Minneapolis, MN is involved with conducting 391 clinical trials across 349 conditions. There are 31 research doctors associated with this hospital, such as Mark A. Klein, Sharon D. Luikart, Santiago Garcia, MD, and Kelvin Lim, MD.
Where is Minneapolis VA Health Care System, Minneapolis, MN located?
The Minneapolis VA Health Care System is situated at One Veterans Drive, Minneapolis, MN 55417. For directions from St. Paul, take 35E South to the West 7th Street/State Route 5 exit, then follow signs for U.S. 55 West and Fort Snelling. For customized driving directions, consider using Google Maps or Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at the Minneapolis VA Health Care System, patients can contact the billing and insurance department directly. The main contact number is 612-725-2000, with a toll-free option available at 866-414-5058. Additionally, for assistance with care or resolving issues, a patient advocate can be reached for support.
What insurance does Minneapolis VA Health Care System, Minneapolis, MN accept?
The Minneapolis VA Health Care System in Minneapolis, MN, primarily serves veterans through insurance plans provided by the Department of Veterans Affairs (VA), covering health, support, and facility services in Minnesota and western Wisconsin. Veterans receiving care here benefit from no copays for essential services including X-rays, lab tests, and preventative care. Additionally, the VA offers health insurance for its employees, with premiums partially subsidized.
What awards or recognition has Minneapolis VA Health Care System, Minneapolis, MN received?
The Minneapolis VA Health Care System is renowned for its extensive research program, featuring over 150 investigators and more than 500 projects funded by various prestigious sources. It boasts affiliations with the University of Minnesota and has earned accolades for innovations such as the Habit Camera, Wand-based camera, and its unique approaches to mental health treatment. Additionally, the hospital houses four major research centers and is an active participant in numerous national research initiatives.